Literature DB >> 8956330

The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide.

S Gangwar1, S D Jois, T J Siahaan, D G Vander Velde, V J Stella, R T Borchardt.   

Abstract

PURPOSE: To determine the different conformations of the acyloxyalkoxy-linked cyclic prodrug 1 of the model hexapeptide 2 in solution and to investigate the relationship between these solution conformations and the cellular permeability characteristics of this prodrug.
METHODS: Two-dimensional Homonuclear Hartmann-Hahn spectroscopy, Rotating-Frame Overhouser effect spectroscopy, circular dichroism and molecular dynamics simulations were used to find the solution conformers of cyclic prodrug 1.
RESULTS: Our spectroscopic findings suggest that cyclic prodrug 1 exhibits a major and a minor conformer in solution. The major conformer appears to have a well-defined secondary structure, which involves a beta-turn and 4-->1 intramolecular hydrogen bond, creating a compact structure with a reduced average hydrodynamic radius compared to the model hexapeptide 2.
CONCLUSIONS: The increased ability of cyclic prodrug 1 to permeate membranes compared to the model hexapeptide 2 could be due to reduction in the average hydrodynamic radius of the molecule facilitating paracellular flux and/or the reduction in the hydrogen bonding potential facilitating transcellular flux.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956330     DOI: 10.1023/a:1016484522113

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide.

Authors:  A Perczel; K Park; G D Fasman
Journal:  Anal Biochem       Date:  1992-05-15       Impact factor: 3.365

2.  An explanation for the rare occurrence of cis peptide units in proteins and polypeptides.

Authors:  G N Ramachandran; A K Mitra
Journal:  J Mol Biol       Date:  1976-10-15       Impact factor: 5.469

3.  Quantitative analysis of cyclic beta-turn models.

Authors:  A Perczel; G D Fasman
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

Review 4.  Turns in peptides and proteins.

Authors:  G D Rose; L M Gierasch; J A Smith
Journal:  Adv Protein Chem       Date:  1985

5.  The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability.

Authors:  R A Conradi; A R Hilgers; N F Ho; P S Burton
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

6.  Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier.

Authors:  W T Cefalu; W M Pardridge
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

7.  Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy.

Authors:  H D Kleinert; S H Rosenberg; W R Baker; H H Stein; V Klinghofer; J Barlow; K Spina; J Polakowski; P Kovar; J Cohen
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

  7 in total
  13 in total

1.  Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonist.

Authors:  H Saitoh; B J Aungst
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

3.  Esterase-sensitive cyclic prodrugs of peptides: evaluation of a phenylpropionic acid promoiety in a model hexapeptide.

Authors:  G M Pauletti; S Gangwar; B Wang; R T Borchardt
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

Review 4.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

5.  A randomly coiled, high-molecular-weight polypeptide exhibits increased paracellular diffusion in vitro and in situ relative to the highly ordered alpha-helix conformer.

Authors:  Nazila Salamat-Miller; Montakarn Chittchang; Ashim K Mitra; Thomas P Johnston
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

6.  The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers.

Authors:  G T Knipp; D G Vander Velde; T J Siahaan; R T Borchardt
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

7.  The effect of beta-turn structure on the permeation of peptides across monolayers of bovine brain microvessel endothelial cells.

Authors:  M Sorensen; B Steenberg; G T Knipp; W Wang; B Steffansen; S Frokjaer; R T Borchardt
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

8.  Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.

Authors:  Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

9.  Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.

Authors:  O S Gudmundsson; G M Pauletti; W Wang; D Shan; H Zhang; B Wang; R T Borchardt
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

10.  Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.

Authors:  A Bak; O S Gudmundsson; G J Friis; T J Siahaan; R T Borchardt
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.